Jeremy Aryeh Mazurek, MD, FACC
Assistant Professor of Clinical Medicine (Cardiovascular Medicine)
Program Director, Pulmonary Hypertension/Pulmonary Vascular Disease Fellowship Program
Medical Director, Pulmonary Hypertension Program, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
3400 Civic Center Blvd
Perelman Center 11th Floor South 11-179
Philadelphia, PA 19104
3400 Civic Center Blvd
Perelman Center 11th Floor South 11-179
Philadelphia, PA 19104
Office: 2156150718
Fax: 215-349-8309
Fax: 215-349-8309
Publications
Education:
BA (Economics)
Yeshiva University, 2004.
MD (Medicine)
Albert Einstein College of Medicine of Yeshiva University, 2008.
Cert (Clinical research Certificate/ Epidemiology and Biostatistics)
Perelman School of Medicine at the University of Pennsylvania, 2015.
Permanent linkBA (Economics)
Yeshiva University, 2004.
MD (Medicine)
Albert Einstein College of Medicine of Yeshiva University, 2008.
Cert (Clinical research Certificate/ Epidemiology and Biostatistics)
Perelman School of Medicine at the University of Pennsylvania, 2015.
Description of Clinical Expertise
Pulmonary HypertensionChronic Thromboembolic Pulmonary Hypertension & Pulmonary Thromboendarterectomy
Right Sided Heart Failure
Heart Failure
Cardiomyopathy
Ventricular Assist Devices
Valvular Heart Disease
Heart Transplantation
Post-Transplant Follow-Up
Right Heart Catheterization
Endomyocardial Biopsy
Cardiopulmonary Exercise Testing
Description of Research Expertise
Pulmonary HypertensionHeart Failure with Reduced Ejection Fraction
Heart Failure with Preserved Ejection Fraction
Hemodynamics
Cardiopulmonary Exercise Testing
Biomarkers
Echocardiography
Right Ventricular Failure
Selected Publications
Broderick KL, Peters CJ, Mazurek JA, Wald J, Zhang RS, Atluri P, Urgo K, Goldberg L, Blumberg EA, Weikert BC, Birati EY.: Characteristics and Outcomes of Candidemia in Patients with Durable Left Ventricular Assist Device Support. ASAIO J 68(8): 1044-1047, August 2022.McCarthy BE, McClelland RL, Appleby DH, Moutchia JS, Minhas JK, Min J, Mazurek JA, Smith KA, Fritz JS, Pugliese SC, Urbanowicz RJ, Holmes JH, Palevsky HI, Kawut SM, Al-Naamani N.: BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis. Chest 162(2): 436-447, August 2022.
Min J, Appleby DH, McClelland RL, Minhas J, Holmes JH, Urbanowicz RJ, Pugliese SC, Mazurek JA, Smith KA, Fritz JS, Palevsky HI, Moutchia Suh J, Al-Naamani N, Kawut SM.: Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants. Ann Am Thorac Soc 19(6): 952-961, June 2022.
Minhas J, Baird G, Appleby D, McClelland R, Min J, Mazurek J, Ventetuolo CE, Al-Naamani N, Kawut SM: Terminal Digit Preference in Pulmonary Hypertension Endpoints. Am J Respir Crit Care Med 205(12): 1482-1485, June 2022.
Zhang RS, Hanff TC, Peters CJ, Evans PT, Marble J, Rame JE, Atluri P, Urgo K, Tanna MS, Mazurek JA, Acker MA, Cevasco M, Birati EY, Wald JW. : Left Ventricular Assist Device as a Bridge to Recovery: Single Center Experience of Successful Device Explantation ASAIO J 68(6): 822-828, June 2022.
LaPatra T, Baird GL, Goodman R, Pinder D, Gaffney M, Klinger JR, Palevsky HI, Fritz J, Mullin CJ, Mazurek JA, Kawut SM, Ventetuolo CE.: Remote 6-Minute-Walk Testing in Patients with Pulmonary Hypertension: A Pilot Study. Am J Respir Crit Care Med 205(7): 851-854, April 2022.
Rali AS, Ranka S, Mazurek JA, Brinkley MD, Cedars A, Clark D, Do N, Lazzara GE, Punnoose L, Sandhaus E, Shah A, Taduru S, Wigger M, Zalawadiya S, Rogers J, Lindenfeld J, Schlendorf K, Menachem JN. : Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases. J Card Fail 28(3): 415-421, March 2022.
Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS, Gao Q, Hasenfuß G, Kahwash R, Kaye DM, Litwin SE, Lurz P, Massaro JM, Mohan RC, Ricciardi MJ, Solomon SD, Sverdlov AL, Swarup V, van Veldhuisen DJ, Winkler S, Leon MB; REDUCE LAP-HF II investigators.: Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet 399(10330): 1130-1140, March 2022.
Edelson JB, Edwards JJ, Katcoff H, Mondal A, Chen F, Reza N, Hanff TC, Griffis H, Mazurek JA, Wald J, Burstein DS, Atluri P, O'Connor MJ, Goldberg LR, Zamani P, Groeneveld PW, Rossano JW, Lin KY, Birati EY. : Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk Score. J Am Heart Assoc 11(2): e020942, January 2022.
Goodman R, Chirinos JA, Ky B, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Pugliese SC, Kawut SM, Al-Naamani N. : Systemic arterial properties in pulmonary hypertension. Pulm Circ 11(4): 20458940211055684, November 2021.